WallStSmart

PepsiCo Inc (PEP)vsArcadia Biosciences Inc (RKDA)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

PepsiCo Inc generates 2005974% more annual revenue ($95.45B vs $4.76M). PEP leads profitability with a 9.2% profit margin vs -195.9%. PEP earns a higher WallStSmart Score of 62/100 (C+).

PEP

Buy

62

out of 100

Grade: C+

Growth: 6.0Profit: 8.0Value: 4.7Quality: 4.0
Piotroski: 3/9Altman Z: 2.26

RKDA

Hold

38

out of 100

Grade: F

Growth: 4.0Profit: 2.0Value: 6.7Quality: 5.3
Piotroski: 3/9Altman Z: -62.62
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

PEPFair Value (-2.5%)

Margin of Safety

-2.5%

Fair Value

$138.40

Current Price

$141.92

$3.52 premium

UndervaluedFair: $138.40Overvalued
RKDAUndervalued (+37.9%)

Margin of Safety

+37.9%

Fair Value

$2.80

Current Price

$1.03

$1.77 discount

UndervaluedFair: $2.80Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

PEP3 strengths · Avg: 9.0/10
Return on EquityProfitability
40.9%10/10

Every $100 of equity generates 41 in profit

Market CapQuality
$194.11B9/10

Large-cap with strong market position

EPS GrowthGrowth
27.8%8/10

Earnings expanding 27.8% YoY

RKDA2 strengths · Avg: 9.0/10
Price/BookValuation
0.7x10/10

Reasonable price relative to book value

EPS GrowthGrowth
28.5%8/10

Earnings expanding 28.5% YoY

Areas to Watch

PEP4 concerns · Avg: 3.3/10
PEG RatioValuation
1.524/10

Expensive relative to growth rate

Price/BookValuation
9.1x4/10

Trading at 9.1x book value

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Free Cash FlowQuality
$-406.00M2/10

Negative free cash flow — burning cash

RKDA4 concerns · Avg: 2.5/10
Market CapQuality
$1.94M3/10

Smaller company, higher risk/reward

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Return on EquityProfitability
-323.1%2/10

ROE of -323.1% — below average capital efficiency

Revenue GrowthGrowth
-8.3%2/10

Revenue declined 8.3%

Comparative Analysis Report

WallStSmart Research

Bull Case : PEP

The strongest argument for PEP centers on Return on Equity, Market Cap, EPS Growth.

Bull Case : RKDA

The strongest argument for RKDA centers on Price/Book, EPS Growth.

Bear Case : PEP

The primary concerns for PEP are PEG Ratio, Price/Book, Piotroski F-Score. Debt-to-equity of 2.47 is elevated, increasing financial risk.

Bear Case : RKDA

The primary concerns for RKDA are Market Cap, Piotroski F-Score, Return on Equity.

Key Dynamics to Monitor

PEP profiles as a value stock while RKDA is a turnaround play — different risk/reward profiles.

RKDA carries more volatility with a beta of 0.50 — expect wider price swings.

PEP is growing revenue faster at 8.5% — sustainability is the question.

RKDA generates stronger free cash flow (-1M), providing more financial flexibility.

Bottom Line

PEP scores higher overall (62/100 vs 38/100). RKDA offers better value entry with a 37.9% margin of safety. Both earn "Buy" and "Hold" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

PepsiCo Inc

CONSUMER DEFENSIVE · BEVERAGES - NON-ALCOHOLIC · USA

PepsiCo, Inc. is an American based multinational food, snack, and beverage corporation headquartered in Harrison, New York, in the hamlet of Purchase. PepsiCo's business encompasses all aspects of the food and beverage market. It oversees the manufacturing, distribution, and marketing of its products.

Arcadia Biosciences Inc

CONSUMER DEFENSIVE · PACKAGED FOODS · USA

Arcadia Biosciences, Inc. is dedicated to developing various crop productivity traits primarily in hemp, wheat, and soybeans. The company is headquartered in Davis, California.

Visit Website →

Want to dig deeper into these stocks?